The loss of immunohistochemical expression of BAP1 helps to make the correct diagnosis in many cases in which the differential diagnosis is between epithelioid mesothelioma and reactive hyperplasia. This evidence concerns the gene BAP1 and malignant epithelioid mesothelioma.